used the probiotic yeast Saccharomyces boulardii to produce recombinant exendin-4
Tam FW-M, Taki M (2007) Bullying among girls in Japan and Hong Kong: an examination of the frustration-aggression model
Results May Vary: Individual results will vary based on factors including age, baseline health condition, starting weight, metabolic factors, consistency of use, adherence to lifestyle modifications, genetic factors, current medications, and other individual variables
These disruptions include a reduction in SCFA producers and an increase in bacteria associated with inflammation and metabolic endotoxemia, which may serve as potential biomarkers for disease progression and severity
Key variants such as GIPR rs1800437 and GLP1R rs6923761 provide biological context for how your body may metabolize and respond to GLP-1 agonists
Its also simply the drug both doctors are most familiar with